Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- CheckyesterdayChange DetectedMedullary thyroid carcinoma and adrenal cortex carcinoma were added to the list of conditions. Deletions occurred on 2026-03-24 and 2026-03-25.SummaryDifference0.1%

- Check9 days agoChange Detected**Release log update:** Added entries for 2026-03-25 and 2026-03-24 and updated to Revision v3.5.0. Removed entries for 2026-03-17 and 2026-03-14 with the previous Revision v3.4.3.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded Rhabdomyosarcoma and Hepatocellular carcinoma to the condition list. Removed entries on 2026-03-07 and 2026-03-10.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision notes updated to include v3.4.3 with dates 2026-03-07 and 2026-03-10. Legacy entry v3.4.2 was removed (dates 2026-02-11 and 2026-03-03).SummaryDifference0.1%

- Check30 days agoChange DetectedThe Study Record Dates were updated with new entries (2026-03-03, 2026-02-11, 2025-12) and older entries (2025-12-02, 2025-11-14, 2025-06) were removed.SummaryDifference0.1%

- Check44 days agoChange DetectedNo significant changes detected; the study details page content and layout remain consistent with its purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.